| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Study on Clinical Features, Treatment Mode and Survival of Sarcoma (NCT05453409) | Henan Cancer Hospital | 2022-06-07 |
| GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers (NCT06076070) | Regina Elena Cancer Institute | 2022-05-25 |
| Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients (NCT05396118) | Rigshospitalet, Denmark | 2022-05-18 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors (NCT05121545) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-06 |
| Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan (NCT06482957) | Vanderbilt-Ingram Cancer Center | 2022-04-01 |
| A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05238883) | HiFiBiO Therapeutics | 2022-03-10 |
| Cryoablation for Advanced Bone and Soft Tissue Tumors (NCT05615545) | Henan Cancer Hospital | 2022-03-10 |
| Investigating Cognitive Impairment in Young Patients With Cancer Prospectively (NCT05840575) | Rigshospitalet, Denmark | 2022-03-01 |
| Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study (NCT05169151) | M.D. Anderson Cancer Center | 2022-02-17 |
| A Study of PRT2527 in Participants With Advanced Solid Tumors (NCT05159518) | Prelude Therapeutics | 2022-02-14 |
| Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy (NCT05057195) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors (NCT05057130) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid (NCT05578820) | Gene Surgery LLC | 2022-01-01 |
| Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma (NCT05106777) | Sun Yat-sen University | 2021-12-10 |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (NCT04995003) | Baylor College of Medicine | 2021-12-07 |
| Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients (NCT07432932) | Royal Marsden NHS Foundation Trust | 2021-11-19 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall. (NCT04960332) | Rigshospitalet, Denmark | 2021-07-01 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype (NCT04741438) | Centre Leon Berard | 2021-03-30 |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (NCT04673942) | EpicentRx, Inc. | 2021-03-29 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT04742959) | TransThera Sciences (Nanjing), Inc. | 2021-03-14 |
| Fluorescent Intra-operative Tumor Margin Examination (NCT04719156) | Kurt Weiss | 2021-03-02 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (NCT04628806) | Charite University, Berlin, Germany | 2021-02-17 |
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
| Economic Evaluation of Sarcoma Patients Management in France (NCT05272358) | Centre Leon Berard | 2021-02-08 |
| Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT) (NCT04893356) | National Cancer Institute, Naples | 2021-01-20 |
| Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers (NCT04072393) | Washington University School of Medicine | 2021-01-15 |
| Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. (NCT04802070) | Prof. Franca Fagioli | 2021-01-11 |
| Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children (NCT05179850) | West China Hospital | 2021-01-01 |
| Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing (NCT06291662) | Kathleen McGreevy | 2021-01-01 |
| Spine and Tumor Screening and Supplementation (NCT03660540) | University of Iowa | 2021-01-01 |
| Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. (NCT03782363) | Italian Sarcoma Group | 2020-12-18 |
| Enhanced Recovery After Surgery in Extremity Sarcoma (NCT04461171) | Joshua Lawrenz | 2020-12-14 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| Augmented Reality (AR): The Future of "Patient Information Leaflets (NCT04619030) | NHS Greater Glasgow and Clyde | 2020-11-30 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) (NCT04634227) | University of Iowa | 2020-11-24 |
| Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma (NCT03880123) | Matthew Ingham | 2020-11-01 |
| Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma? (NCT04512495) | Institut Claudius Regaud | 2020-10-22 |
| GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma (NCT04535713) | Sarcoma Oncology Research Center, LLC | 2020-09-30 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. (NCT04367779) | Centre Leon Berard | 2020-09-24 |
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
| Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers (NCT04553692) | IGM Biosciences, Inc. | 2020-09-23 |
| Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers (NCT04553471) | Washington University School of Medicine | 2020-09-22 |
| A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (NCT04370587) | ImmVira Pharma Co. Ltd | 2020-09-17 |
| 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma (NCT04457258) | Jonsson Comprehensive Cancer Center | 2020-09-08 |
| Using QPOP to Predict Treatment for Sarcomas and Melanomas (NCT04986748) | National Cancer Centre, Singapore | 2020-09-08 |
| Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") (NCT04474678) | Medical University of Vienna | 2020-09-07 |
| Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial (NCT04190433) | Mayo Clinic | 2020-09-01 |
| Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy (NCT04517019) | University Hospital Tuebingen | 2020-08-01 |
| Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors (NCT04556669) | Hebei Senlang Biotechnology Inc., Ltd. | 2020-08-01 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors (NCT04511871) | Shanghai PerHum Therapeutics Co., Ltd. | 2020-07-09 |
| A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS (NCT04447274) | Chinese Academy of Medical Sciences | 2020-07-01 |
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (NCT04273061) | British Columbia Cancer Agency | 2020-06-17 |
| Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) (NCT03548428) | Centre Antoine Lacassagne | 2020-06-04 |
| Translation and Validation of the German Version of the Toronto Extremity Salvage Score (TESS) and Musculoskeletal Tumor Society (MSTS) (NCT04327908) | Medical University Innsbruck | 2020-06-01 |
| Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® (NCT04033081) | CivaTech Oncology | 2020-04-30 |
| A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors (NCT05602792) | ImmVira Pharma Co. Ltd | 2020-04-21 |
| A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg (NCT04332874) | Memorial Sloan Kettering Cancer Center | 2020-04-01 |
| Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma (NCT04076579) | University of Michigan Rogel Cancer Center | 2020-03-17 |
| Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas (NCT04242238) | Memorial Sloan Kettering Cancer Center | 2020-01-22 |
| Chidamide Combined With Toripalimab in Sarcoma (NCT04025931) | Sun Yat-sen University | 2020-01-19 |
| SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma (NCT03778996) | Sarcoma Oncology Research Center, LLC | 2020-01-03 |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease (NCT01125449) | Situs Cancer Research Center | 2020-01-01 |
| Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas (NCT04101123) | Martin-Luther-Universität Halle-Wittenberg | 2020-01-01 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers (NCT03935893) | Udai Kammula | 2019-12-03 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
| Applying PET/MR in Oncology - a Prospective Project (NCT04158414) | Tel-Aviv Sourasky Medical Center | 2019-11-28 |
| MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma (NCT04074564) | HRYZ Biotech Co. | 2019-11-22 |
| BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma (NCT04072042) | Ruijin Hospital | 2019-10-30 |
| Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care (NCT04300257) | Kantonsspital Winterthur KSW | 2019-10-19 |
| Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma (NCT03628209) | H. Lee Moffitt Cancer Center and Research Institute | 2019-10-03 |
| Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma (NCT04052334) | H. Lee Moffitt Cancer Center and Research Institute | 2019-09-27 |
| Registration Study Sarcoma (NCT05373810) | Radboud University Medical Center | 2019-07-29 |
| The Sarcoma Biology and Outcome Project (NCT04758325) | Prof. Dr. Richard F Schlenk | 2019-07-23 |
| Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies (NCT04149691) | Celon Pharma SA | 2019-07-19 |
| Progressive Resistance Training for the Improvement of Physical Function (NCT04247425) | OHSU Knight Cancer Institute | 2019-06-28 |
| Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma (NCT03896620) | Medical College of Wisconsin | 2019-06-18 |
| A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas (NCT03899805) | Dana-Farber Cancer Institute | 2019-06-04 |
| Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma (NCT04126993) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors (NCT04354064) | Washington University School of Medicine | 2019-05-29 |
| Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma (NCT03886311) | Sarcoma Oncology Research Center, LLC | 2019-05-15 |
| Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults (NCT03670927) | Institut National de la Santé Et de la Recherche Médicale, France | 2019-04-25 |
| A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma (NCT03798106) | Yonsei University | 2019-04-10 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers (NCT03829436) | Tempest Therapeutics | 2019-03-20 |
| PROactive Evaluation of Function to Avoid CardioToxicity (NCT03862131) | Washington University School of Medicine | 2019-03-13 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |